Published in FASEB J on December 01, 2000
A competitive inhibitor traps LeuT in an open-to-out conformation. Science (2008) 4.86
Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci U S A (2008) 2.53
Metabolic control of vesicular glutamate transport and release. Neuron (2010) 2.44
Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. FASEB J (2013) 2.12
Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol (2011) 1.84
Cholinergic chemosensory cells in the trachea regulate breathing. Proc Natl Acad Sci U S A (2011) 1.44
Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol (2008) 1.42
Structural conservation in the major facilitator superfamily as revealed by comparative modeling. Protein Sci (2004) 1.36
The Ras/cAMP/protein kinase A pathway regulates glucose-dependent assembly of the vacuolar (H+)-ATPase in yeast. J Biol Chem (2008) 1.33
The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflugers Arch (2003) 1.31
The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol Cell Biol (2009) 1.27
The epithelial cholinergic system of the airways. Histochem Cell Biol (2008) 1.17
Proteomic analysis of the mitochondria from embryonic and postnatal rat brains reveals response to developmental changes in energy demands. J Proteomics (2014) 1.16
VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci (2011) 1.12
The evolution of dopamine systems in chordates. Front Neuroanat (2011) 1.11
Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway proteins. J Cell Sci (2009) 1.07
Vesicular and plasma membrane transporters for neurotransmitters. Cold Spring Harb Perspect Biol (2012) 1.02
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. Med Res Rev (2010) 0.99
Presynaptic regulation of quantal size: K+/H+ exchange stimulates vesicular glutamate transport. Nat Neurosci (2011) 0.96
SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med (2013) 0.93
Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. Cell Mol Neurobiol (2007) 0.89
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev (2017) 0.87
Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates. Eur J Nucl Med Mol Imaging (2007) 0.87
Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporter. J Neurochem (2010) 0.86
Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? Front Cell Neurosci (2013) 0.86
Drosophila melanogaster as a genetic model system to study neurotransmitter transporters. Neurochem Int (2014) 0.85
A putative vesicular transporter expressed in Drosophila mushroom bodies that mediates sexual behavior may define a neurotransmitter system. Neuron (2011) 0.85
Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine. J Biol Chem (2013) 0.85
The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int (2014) 0.84
Search for the acetylcholine and vesamicol binding sites in vesicular acetylcholine transporter: the region around the lumenal end of the transport channel. J Neurochem (2010) 0.82
Possible important pair of acidic residues in vesicular acetylcholine transporter. Biochemistry (2010) 0.82
Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol. Biochemistry (2009) 0.82
Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction. PLoS One (2013) 0.81
B6eGFPChAT mice overexpressing the vesicular acetylcholine transporter exhibit spontaneous hypoactivity and enhanced exploration in novel environments. Brain Behav (2013) 0.81
Identification of a mammalian vesicular polyamine transporter. Sci Rep (2014) 0.80
Signals involved in targeting membrane proteins to synaptic vesicles. Cell Mol Neurobiol (2002) 0.79
Conformational Propensities of Peptides Mimicking Transmembrane Helix 5 and Motif C in Wild-type and Mutant Vesicular Acetylcholine Transporters. ACS Chem Neurosci (2010) 0.77
Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine. Toxicol Sci (2014) 0.76
VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions. Skelet Muscle (2016) 0.75
Immunomodulatory Effects Mediated by Dopamine. J Immunol Res (2016) 0.75
Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis. Proc Natl Acad Sci U S A (2016) 0.75
Crystal structures of MdfA complexed with acetylcholine and inhibitor reserpine. Biophys Rep (2016) 0.75
Unique pH dynamics in GABAergic synaptic vesicles illuminates the mechanism and kinetics of GABA loading. Proc Natl Acad Sci U S A (2016) 0.75